Free Trial

Atlantic Coastal Acquisition Corp. II (ACABW) Competitors

$0.06 0.00 (0.00%)
As of 01/17/2025

ACABW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, BFRIW, BTMDW, BCTXW, CELUW, and CINGW

Should you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.

Atlantic Coastal Acquisition Corp. II vs.

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and 180 Life Sciences (NASDAQ:ATNFW) are both financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
180 Life Sciences N/A N/A N/A

Atlantic Coastal Acquisition Corp. II and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Atlantic Coastal Acquisition Corp. IIN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
180 Life Sciences Neutral

Summary

Atlantic Coastal Acquisition Corp. II and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACABW vs. The Competition

MetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$58.24M$3.82B$9.14B
Dividend YieldN/A5.01%4.44%4.02%
P/E RatioN/A38.15426.9917.36
Price / SalesN/A910.892,915.9077.11
Price / CashN/A217.8152.6435.97
Price / BookN/A22.141.894.79
Net IncomeN/A-$537,777.78$437.23M$225.00M
7 Day PerformanceN/A0.32%2.71%2.37%
1 Month PerformanceN/A7.02%4.88%4.40%
1 Year PerformanceN/A4.95%14.47%20.10%

Atlantic Coastal Acquisition Corp. II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
flat
N/AN/A$0.00N/A0.004Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+73.1%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A+3.8%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.17
flat
N/AN/A$0.00$40,633.000.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$3.16
-1.3%
N/A-4.2%$0.00$391.87M0.004News Coverage
Positive News
Gap Up
BFRIW
Biofrontera
N/A$0.08
flat
N/AN/A$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.51
flat
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.15
flat
N/A-92.7%$0.00N/A0.008Short Interest ↑
CELUW
Celularity
N/A$0.03
flat
N/AN/A$0.00$48.20M0.00220
CINGW
Cingulate
N/A$0.08
+8.4%
N/AN/A$0.00N/A0.0020Gap Down

Related Companies and Tools


This page (NASDAQ:ACABW) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners